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BRIEF DEFINITIVE REPORT
        Plasmacytoid pre-DCs (pDCs) are the main type I 
IFN producers in humans and mice (  1  ). They 
play a key role in innate antiviral immune re-
sponses but can also evolve into potent APCs and 
be important players in adaptive response (  1, 2  ). 
Activation of pDCs through Toll-like receptor 
(TLR) 7 and 9 can trigger both types of response, 
including large quantities of type I IFN pro-
duction and/or DC diff  erentiation (  1  ). Synthetic 
CpG-containing oligonucleotides of the types 
A and B (CpG-A and -B) selectively induce type I 
IFN production and DC diff  erentiation, respec-
tively (  3  ), whereas some microbial stimuli such 
as influenza virus (Flu), HSV, or CpG-C can 
simultaneously induce both responses (  1  ). Two 
factors seem to be key for the induction of large 
quantities of type I IFN in pDCs: (a) the ability of 
the TLR ligand to bind its receptor in the early 
endosomal compartments (  4, 5  ) and (b) the 
phosphorylation and nuclear translocation of 
the transcription factor IFN regulatory factor 
(IRF) 7 (  6  ). This last step was shown to depend 
on IL-1 receptor  –  associated kinase 1 (  7  ) and I    B 
kinase (IKK)      (  8  ) in mouse pDCs. However, 
the molecular switch regulating type I IFN pro-
duction versus DC diff  erentiation in pDCs is 
not fully elucidated and could have important 
clinical implications, considering the link be-
tween a dysregulated TLR-induced IFN re-
sponse and autoimmune diseases (  9, 10  ). 
  The phosphatidylinositol-3 kinase (PI3K) 
pathway is involved in a variety of biological 
processes, including cell survival and prolifera-
tion, B and T cell receptor signaling, and activa-
tion of G protein  –  coupled receptors, such as 
chemokine receptors (  11  ). PI3K contains regu-
latory subunits (p85      and     ) and catalytic sub-
units (p110     ,     ,     , and     ). PI3K      and      are 
preferentially expressed in cells of hemopoietic 
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  Plasmacytoid predendritic cells (pDCs) are the main producers of type I interferon (IFN) in 
response to Toll-like receptor (TLR) stimulation. Phosphatidylinositol-3 kinase (PI3K) has 
been shown to be activated by TLR triggering in multiple cell types; however, its role in pDC 
function is not known. We show that PI3K is activated by TLR stimulation in primary hu-
man pDCs and demonstrate, using specifi  c inhibitors, that PI3K is required for type I IFN 
production by pDCs, both at the transcriptional and protein levels. Importantly, PI3K was 
not involved in other proinfl  ammatory responses of pDCs, including tumor necrosis factor       
and interleukin 6 production and DC differentiation. pDCs preferentially expressed the PI3K 
      subunit, which was specifi  cally involved in the control of type I IFN production. Although 
uptake and endosomal traffi  cking of TLR ligands were not affected in the presence of PI3K 
inhibitors, there was a dramatic defect in the nuclear translocation of IFN regulatory factor 
(IRF) 7, whereas nuclear factor      B activation was preserved. Thus, PI3K selectively controls 
type I IFN production by regulating IRF-7 nuclear translocation in human pDCs and could 
serve as a novel target to inhibit pathogenic type I IFN in autoimmune diseases. 316 PI3K CONTROLS IRF-7 TRANSLOCATION | Guiducci et al.
suggesting that PI3K may negatively regulate TLR-induced 
infl  ammatory responses in APCs (  13  ). To address its role in 
human pDCs, purifi  ed cells were stimulated with TLR9 (CpG-
C, HSV) or TLR7 (Flu) ligands with or without the phar-
macological inhibitors of PI3K, LY, and wortmannin. These 
TLR ligands induced high levels (20  –  30 ng/ml) of IFN-     
production by freshly sorted pDCs (  Fig. 2 A  ).   This response 
was strongly inhibited by LY in a dose-dependent manner, 
with a maximal eff  ect at 1.25     M LY for both TLR7 and 9 
ligands (  Fig. 2 A  ). A 50% inhibition of IFN-     was still observed 
with LY concentrations as low as 0.08     M for TLR9 (  Fig. 2 A  ). 
Similarly, strong inhibition of IFN-     was observed in CpG-A  –
  stimulated pDCs (Fig. S1, available at http://www.jem
.org/cgi/content/full/jem.20070763/DC1). Importantly, no 
negative eff  ect on pDC viability was observed at any of the 
concentrations used (Fig. S2). Similar results were obtained 
with wortmannin (not depicted), another inhibitor targeting the 
PI3K pathway. 
  Specifi  city of signaling inhibitors can be an issue, especially 
in cultures exceeding several hours. To exclude nonspecifi  c 
eff  ects caused by the potential toxicity of using PI3K inhibitors 
that could aff  ect important functions of pDCs, we performed 
two types of experiments. First, we cultured pDCs for shorter 
periods of 2 and 5 h, and analyzed the ability of PI3K inhibitors 
to inhibit the IFN-     response at the transcriptional level. After 
2 h, we detected signifi  cant IFN-    , -    , and IFN-     messenger 
RNA in the presence of CpG-C, which was almost completely 
inhibited by LY (  Fig. 2 B  ). The same magnitude of inhibition 
origin, whereas expression of PI3K      and      is ubiquitous. 
Accordingly, knockout mice for p110      and      show embryonic 
lethality, whereas knockout mice for p110      and      are viable 
and fertile and show altered phenotypes exclusively when 
their immune system is under acute stress (  12  ). The PI3K path-
way has been shown to be activated by various TLR ligands 
and can function as a positive or negative regulator of TLR 
responses depending on the cell type and the TLR ligand 
used (  13  ). Inhibition of PI3K in mouse myeloid DCs and 
macrophages increased IL-12 production in response to TLR 
stimulation (  13  ), a result compatible with the in vivo obser-
vation of a skewed Th1 response in PI3K p85        	  /  	    mice (  14  ) 
and susceptibility to microbial-induced sepsis in mice through 
an increased production of innate cytokines (  15  ). In mouse 
CD4  +   T cells, MyD88 was recently shown to activate PI3K and 
to enable CpG-mediated proliferation but not survival (  16  ). 
In mouse macrophages, however, CpG oligodeoxynucleo-
tide (ODN) promoted survival through TLR9 and the PI3K 
pathway (  17  ). The function of PI3K in pDCs has not been 
evaluated. Cell type specifi  city of PI3K, as well as discrepan-
cies in the role of PI3K between cell lines and primary cells (  11  ), 
strengthened the need to study this pathway using human 
primary cells. In this report, we show that PI3K activation is 
an important early step in the signaling pathway leading to 
IRF-7 nuclear translocation and type I IFN production after 
TLR7 and 9 activation of human pDCs that diff  erentially 
regulate the IRF-7 and NF-    B signaling pathways. 
    RESULTS AND DISCUSSION   
  TLR ligands induce PI3K-dependent Akt phosphorylation 
in primary human pDCs 
  To assess the activity of PI3K in primary human pDCs, we 
measured phosphorylated Akt (p-Akt), a downstream target 
of PI3K (  11  ). p-Akt was not detected at signifi  cant levels in 
freshly sorted pDCs and was not induced by serum-containing 
medium (  Fig. 1  ), as opposed to other cell-culture systems in 
which serum could induce PI3K activation (  18  ).   However, 
p-Akt was up-regulated at both 20 and 90 min of culture in 
the presence of CpG-C or Flu (  Fig. 1, A and B  ). This increase 
was PI3K dependent because it could be blocked by the spe-
cifi  c PI3K inhibitor LY294002 (LY) at both time points and 
for both TLR ligands (  Fig. 1, A and B  ). TLR9 signaling could 
lead to PI3K activation in diff  erent cell types, such as CD4  +   
T cells (  16  ), mouse macrophages (  17  ), or splenic DCs (  19  ). 
After TLR9 triggering, Akt phosphorylation was observed 
30 min after CpG stimulation (  16, 19  ), which was comparable 
to our data on human pDCs. This rapid response, together 
with the ability of MyD88 to associate to the p85 subunit 
of PI3K (  16  ), supports a direct TLR-induced activation of 
PI3K rather than indirect activation through a TLR-induced 
autocrine loop. 
  Selective involvement of PI3K for type I IFN production 
by TLR-activated pDCs 
  The selective inhibition of PI3K in TLR2, 4, and 9-stimulated 
mouse DCs and macrophages enhanced IL-12 production, 
    Figure 1.         TLR triggering activates the PI3K pathway in human 
pDCs.   Purifi  ed pDCs were cultured with (A) 1     M CpG-C or (B) Flu (multi-
plicity of infection [MOI] = 2) for 20 or 90 min with or without the PI3K 
inhibitor LY at 1     M. Cells were stained with anti  –  p-AKT, as specifi  ed in 
Materials and methods. Representative histograms of at least three 
separate experiments are shown.     JEM VOL. 205, February 18, 2008  317
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  Autocrine IFN-     signaling was shown to account for a 
portion of the induction of chemokines, such as CC chemokine 
ligand (CCL) 2 and IFN-      –  inducible protein 10 (IP-10), in 
response to TLR9 activation (  20  ). Consistent with a strong 
inhibition of IFN-     production, PI3K inhibition induced 
a 70% reduction in the expression of CCL2 and IP-10 in 
CpG-activated pDCs (Fig. S3, available at http://www.jem
.org/cgi/content/full/jem.20070763/DC1). 
  In addition to large amounts of type I IFNs, TLR activation 
of pDCs can induce the production of proinfl  ammatory cyto-
kines such as IL-6 and TNF-    . In contrast to the strong inhibi-
tion of type I IFN, TNF-     and IL-6 production by pDCs in 
response to both TLR9 or 7 ligands was not signifi  cantly aff  ected 
by the addition of LY, even at high (5     M) concentrations of the 
inhibitor (  Fig. 3, A and B  ; and Fig. S1).   This was confi  rmed at 
the transcriptional level (  Fig. 3 C  ). Similarly, the pDCs diff  eren-
tiation into mature DCs, as assessed by surface expression of the 
co-stimulatory molecules CD80 and CD86, was not signifi  cantly 
aff  ected by PI3K inhibitors (  Fig. 3 D  ; and Fig. S4, available at 
http://www.jem.org/cgi/content/full/jem.20070763/DC1). 
These data demonstrate that PI3K is selectively involved in the 
IFN-     pathway but not in the signaling events required for 
TNF-     or maturation induction. Moreover, they show that im-
portant functional pathways are conserved in pDCs despite PI3K 
inhibition, which, together with the conserved viability of pDCs, 
demonstrate that the observed eff  ect on IFN-     was not caused 
by the overall toxicity of the inhibitor. Importantly, the PI3K 
inhibitor wortmannin was previously used as a means to inhibit 
autophagy in Flu-activated mouse pDCs without any eff  ect in 
type I IFN production, suggesting major species-specifi  c diff  er-
ences in the regulation of type I IFN production in human com-
pared with mouse pDCs (  21  ). In contrast to our data, inhibition 
of IFN-     in human pDCs using specifi  c inhibitors of TLRs (  22  ), 
or after cross-linking of surface ILT7 (  23  ) or BDCA2 (  24  ), 
induced a parallel decrease in TNF-     and IL-6 production, sug-
gesting a diff  erent molecular mechanism. 
  To further defi  ne the function of the diff  erent subunits of 
PI3K in human pDCs, we addressed (a) their expression pro-
fi  le and (b) their respective contribution to regulate type I 
IFN in pDCs. First, we show that freshly purifi  ed and acti-
vated pDCs preferentially expressed the p85     regulatory sub-
unit and the p110     catalytic subunit (  Fig. 4 A  ).   Second, the 
PI3K       –  specifi   c inhibitor IC87114 (  25  ) inhibited IFN-     
production in a dose-dependent manner (  Fig. 4 B  ), whereas 
when we cultured pDCs in the presence of the PI3K       –  specifi  c 
inhibitor AS604850, we did not observe any eff  ect on IFN-     
production unless used at high concentration (  >  20     M), where 
its specifi  city for the      subunit is lost (  26  ). These results demon-
strate that the PI3K      subunit is the essential subunit involved 
in the production of IFN-     by pDCs. 
  PI3K inhibition does not affect the uptake and endosomal 
location of CpG ODN 
  CpG ODN requires both uptake and localization into appropri-
ate endosomal compartments to signal through TLR9. It is 
possible that PI3K is required for one or both of these steps, 
was observed at 5 h of culture (  Fig. 2 B  ). Second, we attempted 
to reverse the inhibition of IFN-     production by washing 
out the inhibitor. After 5 h of culture, CpG-induced IFN-     
production was inhibited in the presence of LY (  Fig. 2 C  ). 
Washing out the inhibitor after the fi  rst 5 h enabled pDCs to 
recover their ability to produce large amounts of IFN-     dur-
ing the subsequent 12 h (  Fig. 2 C  ). 
    Figure 2.         P13K inhibition selectively inhibits TLR7- and 9-mediated 
IFN-      response in human pDCs.   (A)  Purifi  ed pDCs were cultured with 
1     M CpG-C, HSV (MOI = 5), or Flu (MOI = 1) either alone or in combina-
tion with various concentration of the PI3K inhibitor LY (in micromolars) 
for 16 h. IFN-     production was evaluated by ELISA. Means of one experi-
ment with 3 independent donors (representative of   >  15 donors) are 
shown. (B) Purifi  ed pDCs were cultured with 1     M CpG-C alone or in the 
presence of 2     M of LY inhibitor for 2 and 5 h. The expression levels of 
IFN-   ,  -   , and -     were measured by real-time PCR. The mean of three 
independent donors is shown. (C) Purifi  ed pDCs were cultured with CpG-C 
or Flu, either alone or in the presence of LY inhibitor. The supernatants 
were collected after 5 h, after which the cells were washed twice and 
restimulated with CpG-C or Flu for another 12 h. IFN-     production  was 
evaluated by ELISA. The mean of three independent donors is shown. Data 
were analyzed using a two-tailed Student  ’  s   t   test.  *,  P   <   0.05.   318 PI3K CONTROLS IRF-7 TRANSLOCATION | Guiducci et al.
  We and others have shown recently that the nature of the 
pDC response to TLR9 strongly depends on the intracellular 
compartment where the receptor/ligand interaction occurs 
(  4, 5  ). In human pDCs, the production of IFN-     is associated 
with the traffi   cking of CpG in the early endosomal compart-
ment, whereas maturation in APCs required accumulation of 
the CpG within the late endosomal compartment (  5  ). We there-
fore investigated whether PI3K inhibition would interfere 
with the localization of the CpG in the early endosome com-
partment, a situation that is predicted to hamper IFN-    response. 
Transferrin receptor and Lamp-1 were used as markers of early 
and late endosomes, respectively. As previously described (  5  ), in 
the absence of PI3K inhibition, fl  uorescent CpG-C colocal-
ized with transferrin receptor  –   as well as Lamp-containing en-
dosomal compartments (Fig. S5 B). This pattern of distribution 
was not aff  ected by PI3K inhibitors, indicating that PI3K 
does not interfere with the intracellular traffi   cking of CpG in 
primary pDCs (Fig. S5, B and C). Importantly, this shows 
that although we cannot exclude that blocking PI3K may 
have some eff  ect on endosomal traffi   cking, it did not prevent 
the localization of the CpG in the early endosome that is es-
sential for triggering IFN-     at time points where inhibition 
of IFN-     was almost complete by gene expression analysis 
(  Fig. 2 B  ). Furthermore, the concentration of LY was similar 
to the one used to demonstrate inhibition of IFN-     at a similar 
time of stimulation (  Fig. 2 B  ). These data show that PI3K does 
not interfere with the uptake and distribution of the TLR li-
gands and suggest that it could be an important player in the 
signaling pathway downstream of TLR7 or 9 activation. 
rather than for signal transduction downstream of TLR9. To test 
the role of PI3K in uptake, we used fl  uorescent CpG ODN 
and demonstrated that inhibiting PI3K with LY or wortmannin 
did not have any eff  ect on CpG uptake, as measured by fl  ow 
cytometry (Fig. S5 A, available at http://www.jem.org/cgi/
content/full/jem.20070763/DC1). PI3K was described to be 
important for phagocytosis and endocytosis in various cellular 
models (  27  ), partly by contributing to phagosome formation 
and maturation (  27, 28  ). In addition, it was previously shown 
that blocking PI3K resulted in a complete blockade of CpG 
ODN uptake in mouse myeloid DCs and TLR9-transfected 
HEK 293 cells (  29  ). Diff  erences in the cell type used could 
account for this discrepancy. 
    Figure 4.         PI3K               is essential for IFN-      production by pDCs in 
response to TLR stimulation.   (A) Expression of class I A p110 (   ,    ,  and    ) 
and class I B (    ) PI3K subunits in human pDCs. Purifi  ed pDCs were cul-
tured for 6 h as indicated, and RNA was extracted and analyzed by quanti-
tative PCR. Expression levels are expressed after normalization to    -actin. 
Data are shown as the mean with standard deviation from three indepen-
dent donors. (B) Purifi  ed pDCs were cultured with 1     M CpG-C, either 
alone or in combination with various concentrations of the PI3K inhibitors 
p110      AS 604850, p110      IC 87114, or LY for 16 h. IFN-     production  was 
measured by ELISA. The mean of three independent donors is shown.     
    Figure 3.         P13K inhibition does not affect infl  ammatory cytokines 
or maturation of pDCs in response to TLR7/9 triggering.   Purifi  ed 
pDCs were cultured with (A) 1     M CpG-C immunostimulatory sequence 
(ISS) or HSV (MOI = 5) or (B) Flu (MOI = 1) either alone or in combination 
with various concentrations of the PI3K inhibitor LY (in micromolars) for 
16 h. IL-6 and TNF-     production were evaluated by ELISA. Means of one 
experiment with 3 independent donors (representative of   >  15 donors) are 
shown. (C) Purifi  ed pDCs were cultured with 1     M CpG-C alone or in the 
presence of 2     M of LY inhibitor for 2 and 5 h. The expression levels of 
IL-6 and TNF-     were measured by real-time PCR. The mean of three 
independent donors is shown. (D) Cells were stimulated as indicated and 
characterized for CD80 and CD86 expression by fl  ow cytometry analysis. 
Data shown are representative of at least 10 donors (see Fig. S4).     JEM VOL. 205, February 18, 2008  319
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to be key for the high magnitude of IFN-     response upon 
TLR7/9 ligation in human pDCs (  30  ). We thus investigated 
whether PI3K alters this pathway by looking at both tran-
scriptional up-regulation of IRF-7 and its ability to migrate 
to the nucleus upon activation. First, we observed that freshly 
  PI3K is required for IRF-7 nuclear translocation 
but not NF-     B phosphorylation in TLR-activated pDCs 
  In mouse pDCs, IFN-     production depends on the activa-
tion and translocation of IRF-7 to the nucleus (  6  ). Moreover 
the strong up-regulation of IRF-7 messenger was suggested 
    Figure 5.         PI3K is critical for the nuclear translocation of IRF-7 in pDCs but does not block IRF-7 up-regulation.   (A)  10 5   purifi  ed pDCs were 
cultured with or without 1     M CpG-C ISS alone or in the presence of 5     M of LY inhibitor. IRF-7 expression was evaluated 2 and 5 h after stimulation by 
real-time PCR. The mean of three independent donors is shown. (B) 2   ×   10  5   purifi  ed pDCs were left untreated or stimulated with CpG alone or in the 
presence of LY inhibitor for 3 h. Cells were visualized using the membrane staining of class II molecule (FITC), whereas the nucleus was identifi  ed using 
DAPI. IRF-7 nuclear translocation was visualized by immunofl  uorescence with IRF-7 antibody (Alexa Fluor 555, red). Representative cells of at least four 
independent donors are shown. Bar, 5     m. (C) Between 50 and 70 cells from at least four different donors were analyzed for IRF-7 translocation in the 
nuclei. Cells were considered positive when at least 20% of the IRF-7 fl  uorescence was localized in the nucleus. (D, left) Purifi  ed pDCs were cultured with 
1     M CpG-C ISS with or without 1 or 5     M of the PI3K inhibitor LY, or 0.5     M of NF-    B inhibitor for 90 min (representative histograms are shown). 
(right) Expression intensity values as mean fl  uorescent intensity (MFI). The mean of three experiments is shown. *, P   <   0.05. (E) Purifi  ed pDCs were 
cultured with 1     M CpG-C ISS with or without 5     M of the PI3K inhibitor LY for 4 h. Nuclear extracts were analyzed for the binding activity of NF-   B 
p50 and p65 family members. Data are shown as the fold of increase to unstimulated (mean   ±   SEM) of three separate experiments.   320 PI3K CONTROLS IRF-7 TRANSLOCATION | Guiducci et al.
type I IFN. Which is the specifi  c target of PI3K, and whether 
the PI3K pathway regulates the function and/or recruitment 
of TNF receptor  –  associated factor 6, osteopontin, or IKK-    , 
will be important questions to be addressed in future studies. 
  The dissection of the molecular mechanisms controlling 
the innate functions of pDCs could uncover new ways to ma-
nipulate these cells in pathological conditions, such as auto-
immune or infectious diseases. There is increasing evidence for 
a role of IFN-     in the development of autoimmunity, and 
pDCs, through their production of high levels of type I IFN, 
were implicated in the pathophysiology of various autoimmune 
diseases, such as systemic lupus erythematosus, psoriasis, or 
Sj  ö  gren  ’  s disease (  9, 10  ). PI3K inhibitors, in particular those 
specifi  cally targeting the      subunit as nonspecifi  c PI3K inhibitors 
could generate toxicity, off  er a unique way to selectively block 
type I IFN production while preserving NF-    B  –  dependent 
responses, which could have important proinfl  ammatory or 
regulatory eff  ects through modulation of T cell responses. 
  MATERIALS AND METHODS 
  Reagents.     Oligonucleotides CpG-C C274 and CpG-A D19 were prepared 
as previously described (  3  ). UV-inactivated HSV-1 was a gift from R. Pyles 
(University of Texas Medical Branch, Galveston, TX). Heat-inactivated 
infl  uenza virus (H1N1, strain A/PR/8/34) was obtained from the American 
Type Culture Collection. PI3K inhibitors (LY and wortmannin), and the 
NF-    B inhibitor (IKK-2 IV) were purchased from Calbiochem. PI3K      in-
hibitor (AS 604850) was purchased from Echelon. PI3K      inhibitor (IC 
87114) was synthesized as previously described (patent application US 
20050261317 A1). 
  Human IFN-    , IL-6, and TNF-     ELISA sets were purchased from PBL 
Biomedical Laboratories; anti-CD123, anti-CD80, anti-CD86, anti-CD71, 
and anti-CD107a were purchased from BD Biosciences; and anti  –  BDCA-2 
was purchased from Miltenyi Biotec. 
  Isolation and stimulation of purifi  ed human cell subsets.     Buff  y coats 
were obtained from the Stanford Blood Center and cells were used under 
internal Institutional Review Board  –  approved protocols, or they were ob-
tained from adult healthy donors at the Saint-Antoine Crozatier Blood Bank, 
where all donors signed informed consent to allow the use of their blood for 
research purposes. This study was approved by the Institut Curie Internal 
Review Board and by the French National Blood Agency. pDCs were iso-
lated either by using positive selection using BDCA-4  –  conjugated beads or 
by using negative depletion (Miltenyi Biotec), as previously described (  35  ). 
pDCs were 94  –  99% BDCA2  +   CD123  +  , as determined by fl  ow cytometry. 
  Detection of p-AKT and NF-       B by fl  ow cytometry.     Negatively puri-
fi  ed pDCs were stimulated with CpG-C, and cells were immediately fi  xed 
with 4% paraformaldehyde for 15 min at 37  °  C. Cells were then washed, 
permeabilized with PermBuff  er III (BD Biosciences) for 30 min on ice, and 
stained with either Alexa Fluor 647 anti  –  human NF-    B p65 (pS529) or with 
Alexa Fluor 647 anti  –  human AKT (pS473; BD Biosciences) for 30 min and 
analyzed by fl  ow cytometry. 
  NF-       B transcription factor binding activity.     Negatively purifi  ed pDCs 
were stimulated and nuclear extracts were prepared. NF-    B activities were 
measured using TransAM NF-    B kits (Active Motif) according to the manu-
facturer  ’  s instructions. 
  Real-time quantitative PCR (TaqMan) analysis.     PCR reactions were 
performed as described previously (  3  ). In brief, threshold cycle (CT) values 
for each gene were normalized to the housekeeping gene ubiquitin or     -actin 
using the formula Eq. 1.8   (HSKGENE)   (100,000), where HSK is the mean CT 
of triplicate housekeeping gene runs, GENE is the mean CT of duplicate 
sorted pDCs constitutively expressed IRF-7 messenger RNA, 
and that its level was increased 2 and 5 h after CpG stimula-
tion (  Fig. 5 A  ).   This transcriptional up-regulation of IRF-7 
was not aff  ected in the presence of PI3K inhibitor (  Fig. 5 A  ). 
We then studied the nuclear translocation of IRF-7. Using 
confocal microscopy, we found that IRF-7 protein was ex-
pressed in the cytoplasm of unstimulated pDCs and did not 
colocalize with the DAPI nuclear staining (  Fig. 5 B  ). MHC 
class II surface staining was used to visualize the pDCs. After 
stimulation with CpG, the majority of IRF-7 translocated to 
the nucleus, as assessed by the colocalization of the IRF-7 
(red) and DAPI (blue) stainings, as well as the reduction of 
detectable IRF-7 staining in the cytoplasmic compartment 
(  Fig. 5 B  ). This process was dramatically decreased in the pres-
ence of a PI3K inhibitor, with the majority of the IRF-7 stain-
ing remaining in the cytoplasm (  Fig. 5 B  ). The total number 
of cells showing nuclear staining of IRF-7 returned to baseline 
levels in the presence of LY (  Fig. 5 C  ). Similar results were 
obtained with both IFN-inducing classes of CpG, A and C, as 
well as with HSV (not depicted). 
  As shown in   Figs. 2 and 3  , PI3K appears to be essential for 
IFN-     response but not for other infl  ammatory cytokines and 
DC diff  erentiation, two responses that were shown in the 
mouse to be mostly NF-    B dependent (  31  ). We show that in 
parallel to IRF-7 activation, CpG-C also induced phosphory-
lation of NF-    B, as assessed by fl  ow cytometry (  Fig. 5 D  ). 
Interestingly, although the NF-    B phosphorylation was inhib-
ited using a specifi  c NF-    B inhibitor, we did not observe any 
signifi  cant eff  ect of the PI3K inhibitor LY (  Fig. 5 D  ). To confi  rm 
that the NF-    B pathway was not aff  ected after PI3K inhibi-
tion, we analyzed pDC nuclear extracts for the binding activ-
ity of NF-   B p50 and p65 subunits. No diff  erence was detected 
in the absence or presence of LY (  Fig. 5 E  ). These data suggest 
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ways in human pDCs . This may not be the case in other cell 
types, as PI3K could favor NF-    B activity in cell lines (  32  ). 
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